Uniquity Bio Names CFO Ahead of Key Trial Readouts
MALVERN, PA — Uniquity Bio has appointed former Goldman Sachs biotechnology banker Matthew Hartzell as chief financial officer as the clinical-stage biotechnology company prepares for multiple Phase II data releases …
Uniquity Bio Names CFO Ahead of Key Trial Readouts Read More